The Global Forum 2024

Almost everyone wants to expand into new markets, strike global partnerships and attract international capital – but this can be more challenging than expected. The need for a strong personal network and deep understanding of market specific conditions, cultural differences and regulatory pathways cannot be overestimated.

So, what to do?
Well, listening to people with key knowledge and relevant experience may shorten your learning curve quite dramatically (and save you from making costly mistakes).
The Global Forum offers a quick path to understanding the regional challenges and will let you connect with local experts, specialized investors and BD&L representatives from Europe, the US and Asia, offering first-hand knowledge on how to make it abroad.
Keynotes and panels will focus on sharing insights and advice on navigating new markets, finding the right partners and cross-border dealmaking, along with presentations from companies who made – or are about to make – the thrilling journey outside the Nordics.
The event is by invitation only, to ensure optimal relevance for all attendants.
Apply below to join us on May 29-30th 2024.

Event venue 

BioStock Global Forum 2024 is hosted at the Auditorium at Medicon Village in Lund.
Address: Scheeletorget 2 
For directions, please visit Medicon Village’s visitor’s site.

Schedule May 29

09:30Registration & Breakfast

10:30Welcoming remarks, BioStock

10:35Expert Insights: How to make Nordic life science companies attractive internationally – A venture investor’s perspective
Johan Kördel, Ph.D., Managing Partner at Sound BioVentures

11:05Panel: Dealmaking in a Global context
Carl Borrebaeck, Professor & Entrepreneur
Hans Jeppsson, CFO at Vicore Pharma

Jens Lindberg, CEO at Medivir

11:35 Initiator Pharma

11:50 Prolight Diagnostics 

12:05Lunch

13:00Expert Insights: Market and IPO trends in the Nordics vs. the US
Peter Legind-Hansen, Director of Global Listing Services at Nasdaq

13:30 Amplio Pharma 

13:45 Simsen Diagnostics

14:00 Envue Technologies (elevator pitch)

14:05 Sorbus Biomedical (elevator pitch)

14:10 Colzyx (elevator pitch)

14:15Coffee & Refreshments

14:45Expert Insights: Accessing China – A booming source of capital and innovation
Ben Wu, Healthcare Director at Agio Capital

15:15 Chordate Medical

15:30 Iconovo

15:45 EpiEndo Pharmaceuticals

16:00Coffee & Refreshments

16:30 WntResearch

16:45Expert Insights: Fusion Pharmaceuticals – From early VC investment to a billion dollar deal
Johan Christenson, MD PhD, Partner at HealthCap 

17:00Panel: Money, Science & Rock n’ Roll – Bridging the gap from the Nordics to the Global scene
Andreas Schmidt, PhD, SVP, Head of Global BD at Singleron Biotechnologies and Founder & Managing Director at Springboard Health Angels

Ben Wu, Healthcare Director at Agio Capital
Stefan Sandström, Founder and CEO at BioSector Ltd.

17:30Closing remarks, BioStock

18:00 Event Dinner at Hypoteket

Schedule May 30

08:00Registration & Breakfast

09:00 Welcoming remarks, BioStock

09:05Expert Insights: Go Big or Stay Home
Andreas Schmidt, PhD, SVP, Head of Global BD at Singleron Biotechnologies and Founder & Managing Director at Springboard Health Angels

09:30Panel: Optimising a clinical development strategy for partnering and investment
Laura Nichols, Senior Director Clinical Operations and Delivery at Aixial Group
Tara Heitner, Head of Global Search and Alliance Management at Ferring Pharmaceuticals
 

09:50Panel: Paving the way for successful Market Access
Fredrik Olsson, CEO at Genovis
Jessica Lundström, Director Market Access at Bristol-Myers Squibb

John Strobel, Managing Partner at LamaMed Access and VP Sales at PlenOptika
Jonas Fredriksson, Global Brand Director, experience from Sobi and Novartis

10:30Coffee & Refreshments

11:00 ExpreS2ion Biotech

11:15 Elicera Therapeutics

11:30Panel: Nordic Innovation & Global Investments
Anu Balendran, Senior Licensing Director Global Business Development at Novo Nordisk

Pieter van der Meijden, Managing Director Healthcare at DNB Markets
Søren Lemonius, Managing Partner at Sunstone Life Science Ventures

12:00Lunch

13:00Expert Insights: Big in Japan! Trends & Opportunities in the world’s 2nd largest healthcare market
Stefan Sandström, Founder and CEO at BioSector Ltd.

13:30 PharmNovo

13:45 Abliva

14:00 Ziccum

14:15Coffee & Refreshments

14:45 Reccan

15:00 Hamlet BioPharma

15:15 Diagonal Bio

15:30Panel: Becoming relevant for the US market
Fiona Law, Partner and Patent Attorney at Potter Clarkson

Philip Siberg, CEO at Senzime
Suresh Pai, Managing Partner at LamaMed Access

16:00 Closing remarks, BioStock

16:15 After work

  Click the image to open the schedule as a pdf


Event Sponsors

Potter Clarkson is one of Europe’s leading full-service IP law firms. 

Our sole objective is to help innovators and investors maximise the value of their business or investments by identifying, protecting, exploiting, and enforcing the required IP rights anywhere in the world.

With regards to biotechnology and the life sciences, our team is one of Europe’s largest.  We are fiercely proud of our reputation as the European IP firm of choice for clients of all sizes, from ambitious start-ups and SMEs through to Big Pharma.

Having worked alongside investors in the Nordics, Germany, and the UK for decades we also know to deliver the comprehensive and commercial view of the IP in an investment required to support the best investment decisions.

With more than 90 pct. of all US biotech, pharma & life science companies listed on Nasdaq, we know how to match savvy investors with trail-blazing inventors.

We are here to support your ideas and the next steps to a public offering that keeps you in control while raising capital to ignite your ambition. By the way, if you want to keep your ambition closer to home, Nasdaq in the Nordic is the leading hub for listed biotech and health care companies in Europe, with strong support from investors and innovation communities across the region.

How to join the Nasdaq family? – Read more here: https://www.nasdaq.com/solutions/listings/markets/nordic/main-market

The Aixial Group is an International Contract Research Organization (CRO), a member of the ALTEN Group, providing services in phase I-IV clinical trials and non-interventional studies. The CRO occupies a unique position in the clinical research industry, supporting biotech across all phases, as an expert in the operational delivery of clinical trials.

Our vision is to conduct clinical trials better than anyone else to help patients and ultimately save lives. We have earned a strong reputation for successfully delivering complex, demanding and innovative clinical trials, with specialist therapeutic expertise in oncology, cell & gene therapy and rare diseases.

Your Global CRO Partner in Clinical Research: TFS HealthScience is a global contractresearch organization that partners with biotechnology and pharmaceutical companiesthroughout their entire clinical development journey. With industry-leading expertise inkey therapeutic areas and demand-driven strategic resourcing, TFS can meet the needsof our partners and sponsors. Our experts are passionate about their disciplines,continually learning, enhancing and dedicating themselves to the success of your trial.

DNB//Back Bay provides healthcare companies with strategic and M&A guidance and execution, licensing and partnering support, a complete range of corporate and investment banking products and services, and full-scale origination and distribution capabilities in global capital markets.

Together, DNB and Back Bay Life Science Advisors hold a unique position bridging the Nordic and US markets, offering support to companies along the full continuum of life science and healthcare. 


Lund – A city full of possibilities

Among cobblestones and half-timbered houses, the medieval city of Lund is merged with modern buildings and innovative environments. The ties to the University are plentiful and the large number of students add their touch to the city.

The beautiful city of Lund is in the heart of the Öresund Region. Pulsating with history and culture, Lund offers a wealth of attractions for international visitors. Enjoy a range of experiences from restaurants, shopping, museums, entertainment and several hotels; all within walking distance. Famous for its University, Lund’s 40,000 students help create a vibrant and multicultural environment. The architecturally striking city centre has plenty of meeting places and green areas including the beautiful Botanical Gardens, the City Park and  “Lundagård” park. The famous cathedral, ”Domkyrkan”, has fascinated visitors since the 12th Century and is the most popular attraction in southern Sweden with its 700,000 visitors each year.

History meets the future

Founded in the 11th Century, Lund is one of Sweden‘s oldest towns. Today, history and tradition meet innovation and the future. Renowned for its visionary thinking, Lund established one of the region’s first coin factories and the oldest Nordic school, ”Katedralskolan” in 1085. The Cathedral was built in the 12th Century and Lund University opened as Sweden‘s second institute of higher learning in 1666.

The mix of Middle Age and modern architecture is home to high-tech industry and a large graduate population. Inventions such as Bluetooth, the artificial kidney, and ultrasound were all researched here. That innovation will continue at Medicon Village, Ideon Science Park and two world-leading science institutions, Max IV and ESS, put Lund on the international map.